Press Releases
 
Looking for ways to measure tumour aggression

Tests show an association between how aggressive a tumour is and the levels of sugar and inflammatory proteins in the blood.

Selangor, Malaysia, 27 November 2018 -- (ACN Newswire) -- Researchers at University Putra Malaysia found a relationship between some markers of inflammation in the body and the aggressiveness of certain malignant tumours.

They conducted full body scans of 31 people with malignant tumours - including cancers of the lung, oesophagus, colon and breast - using a machine that combines positron emission and computed tomography (PET/CT). The scans evaluated tumour malignancy and aggressiveness based on a measurement, called the maximum standardized uptake value (SUVmax). The more a particular radiopharmaceutical tracer is trapped in the cell, the darker it appears on the scan images and the higher the SUVmax. Traditionally, tumours with a SUVmax value of 2.5 grams/millilitre or higher are considered malignant. The group was divided into two based on tumour SUVmax values above or below 6.0.

The team also measured patients' body mass index (BMI), a measure of obesity; fasting blood sugar levels; and blood levels of inflammatory markers including C-reactive protein, a substance produced by the liver in response to inflammation, and interleukin 6, an immune protein that is active during inflammation.

They found strong correlations between SUVmax and C-reactive protein levels. They also found strong correlations between C-reactive protein levels and interleukin 6 levels. Finally there were also strong correlations between interleukin 6 levels, BMI, and fasting blood glucose levels.

They found that fasting blood glucose and interleukin 6 levels in particular were good predictors of tumour aggression. The fasting blood glucose levels rose and the interleukin 6 levels dropped incrementally the higher the tumour SUVmax value was above 6.0. This could mean that rising blood sugar levels in people with tumours having SUVmax values above 6.0 indicates they are becoming increasingly aggressive. Falling interleukin 6 levels in high SUVmax tumours, on the other hand, could indicate effective treatment.

"Serum inflammatory markers and endogenous glucose are associated with a potentially more aggressive malignant cancer," the researchers conclude in their study published in the Pertanika Journal of Science & Technology. "In particular, interleukin 6 may be used as a useful surrogate marker for tumour aggressiveness with an important prognostic value," they write.

Further research, however, is needed to understand why interleukin 6 levels are altered in this way.

Paper Reference: Ahmad Saad, F. F. et al, "The Association of FDG-PET (Suvmax) and Inflammatory Marker in Predicting Tumour Aggressiveness" Pertanika Journal of Science & Technology. 2018
https://bit.ly/2zuNdOF

Distributed for Pertanika Journal of Science & Technology by ResearchSEA.

# # #


Submitted by ACN Newswire, ACN Newswire on Tuesday, 27 November 2018 at 9:12 AM
Category: Science & Research
 
Related News

How to get the most fuel out of microalgae?
Friday, 14 Dec 2018

Global Lithium-ion Battery Market Overview 2018, Demand by Regions, Types and Analysis of Key Player
Thursday, 13 Dec 2018

Harmonic Filter Market - Shares and Strategies of Major Key Players For 2018
Monday, 10 Dec 2018

Water Purifier Market - Economic Outlook, Analysis and Forecasts
Monday, 10 Dec 2018

Wipes Market - Emerging Nations around the World to Offer Lucrative Opportunities
Monday, 10 Dec 2018

Related Events

2019 Asia Pacific Energy Assembly and Awards Dinner
Wednesday, 30 Jan 2019

20th International Union for Quaternary Research Congress (INQUA 2019)
Thursday, 25 Jul 2019

Latest News

EPIC RESEARCH : Special-Report Of 14 December 2018
Friday, 14 Dec 2018

Executive compensation programs private companies
Friday, 14 Dec 2018

Epic Research Daily Agri Commodity Report Of 14 December 2018
Friday, 14 Dec 2018

Bilstein Coilovers
Friday, 14 Dec 2018

EPIC RESEARCH: - Daily Equity Report Of 14 December 2018
Friday, 14 Dec 2018

 
Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2018
Today is Friday, 14 December 2018

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Business
Consumer Technology
Economy
Education
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
Legal/Law
News & Media
Religion
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!


Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.


  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.


    Resources
  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Upcoming Events
  • Advances in Inflammatory Bowel Diseases (AIBD) December 13-15, 2018
  • ICRS Focus Meeting, Milan 2018 - I am Not Ready for Metal
  • 2018 A4M World Congress | Las Vegas, NV
  • Original Emergency Medicine Boot Camp
  • The Heart Beat of Cardiology: Practical Application of Echocardiography

  • Latest Jobs
    Sorry, there are currently no entries posted here.